8GG-32203-38514
2 vaccinations
0 coded responses
28 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 953 / CA
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-20
Registered in v-safe
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Headache, Muscle or body achesAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-24
- 2021-04-30
- 2021-09-19
-
2022-01-26
Dose 2 — Moderna
-
2022-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-28
- 2022-01-29
- 2022-01-30
- 2022-01-31
- 2022-02-01
- 2022-02-04
- 2022-02-09
- 2022-02-16
- 2022-02-23
- 2022-03-02
- 2022-03-11
- 2022-04-27
- 2022-07-27
- 2023-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Janssen/Johnson & Johnson | |
| 2 | 2022-01-26 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.